Advertisement
Research Article

Differences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin

  • S. Swaroop Vedula,

    Affiliation: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

    X
  • Tianjing Li,

    Affiliation: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

    X
  • Kay Dickersin mail

    kdickers@jhsph.edu

    Affiliation: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

    X
  • Published: January 29, 2013
  • DOI: 10.1371/journal.pmed.1001378

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Getting More Generous with the Truth: Clinical Trial Reporting in 2013 and Beyond

Editorial | published 29 Jan 2013 | PLOS Medicine
doi:10.1371/journal.pmed.1001379